Class action claim was brought by Commission Recovery, with Marks & Clerk denying any wrongdoing
GSK’s two patents declared invalid as both attempt to launch first RSV vaccine in UK market
Trial expected next January as judges say appeal bid ‘does not raise an arguable question of law’ over group claims